Drug intelligence / Profile preview

Xiyue Granules

Development stage
Phase 3
Lead developer
Shanghai Traditional Chinese Medicine Dayuanchuang Technology
Modality
Small Molecules
Administration
Oral
01

Overview

Xiyue Granules is a Traditional Chinese Medicine (TCM) compound preparation developed by Shanghai Traditional Chinese Medicine University Yuanchuang Technology Co., Ltd. specifically for the treatment of chronic knee synovitis, often associated with knee osteoarthritis. The formulation is based on classical TCM principles aimed at clearing heat, resolving dampness, and activating blood circulation to alleviate joint swelling and pain. Pharmacological research indicates that Xiyue Granules exerts anti-inflammatory and chondroprotective effects by inhibiting the TLR4/NF-κB signaling pathway, which in turn reduces the production of pro-inflammatory cytokines such as interleukin-1 beta (IL-1β) and tumor necrosis factor-alpha (TNF-α). Additionally, it has been shown to downregulate the expression of matrix metalloproteinases (MMPs), thereby mitigating the degradation of the synovial membrane and articular cartilage.

Brand names
Xiyue Granules
Other names
Xiyue Keli膝悦颗粒
02

Targets

IL1B (Interleukin-1 beta)MMP12 (Macrophage Metalloelastase)NF-κBTLR4 (Toll-like receptor 4)TNFA (Tumor necrosis factor alpha (soluble))

Beyond the preview

Go deeper on Xiyue Granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xiyue Granules.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call